Back to News
Market Impact: 0.38

Benchmark raises Payoneer stock price target on B2B growth strength

PAYOUPWKSMCIAPP
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsFintech
Benchmark raises Payoneer stock price target on B2B growth strength

Benchmark raised Payoneer's price target to $9 from $7 and kept a Buy rating after the company beat Q1 2026 expectations and lifted full-year guidance. Revenue excluding interest income grew 11% year over year, B2B volume rose 44%, and EPS came in at $0.06 versus $0.04 expected on revenue of $261.6 million versus $255.08 million consensus. The note also highlighted improving business mix and a strategic shift toward B2B.

Analysis

The market is starting to re-rate PAYO from a cyclical cross-border payments processor into a higher-quality B2B workflow asset. The important second-order effect is mix shift: if B2B continues to outgrow the legacy merchant leg, margin durability and take-rate stability should improve, which can justify a multiple closer to software-adjacent fintech than payments utilities. That re-rating matters more than near-term EPS beats because the business is moving from volume beta to relationship-driven retention. The likely beneficiaries extend beyond PAYO. UPWK’s extended payout relationship is a useful proof point that PAYO can win/retain embedded finance rails inside platform ecosystems, which should pressure smaller payout specialists that lack global compliance depth and multi-currency infrastructure. Over time, the real competitive moat is not headline growth but the operational friction of switching payout partners once treasury, KYC, and regional settlement workflows are integrated. The main risk is that the current optimism assumes the B2B acceleration persists beyond the next 1-2 quarters. If volume growth normalizes while interest income remains less supportive, the market could quickly compress the multiple back toward a transactional fintech discount. A second risk is concentration: if the upmarket B2B push depends on a handful of large platform or enterprise wins, any loss of a major partner would show up first in growth quality before it hits reported revenue. Contrarian read: the consensus may still be underestimating how much of PAYO’s valuation upside comes from narrative change rather than absolute earnings power. If investors wait for a few more quarters of proof, the stock can re-rate ahead of fundamentals on simple quality improvement and customer mix alone. But if the market is already extrapolating 40%+ B2B growth, the near-term setup becomes more asymmetric for a tactical fade on strength than for chasing after the move.